News & Media


Larner College of Medicine in the Media

The following news and stories about LCOM appeared in local and/or national media.


  • WCAX Interviews Lahey on How to Keep Regional COVID Rates Low
    (AUGUST 12, 2022) Infectious disease specialist Tim Lahey, M.D., M.M.Sc., professor of medicine, spoke to WCAX-TV about what actions people — and public health officials — can take to help keep COVID case rates down in Vermont and Northern New York despite the increased transmissibility of the BA-5 variant.
  • Stein Comments on $20M NIH Grant to Vermont–Maine Partnership, VermontBiz Reports
    (AUGUST 11, 2022) A $20 million grant from the National Institutes of Health to the New England Clinical and Translational Research Network (NNE-CTR) will allow NNE-CTR members from UVM, MaineHealth Institute for Research, and the University of Southern Maine to address chronic and life-threatening diseases in northern New England, VermontBiz reports.
    Read full story at VermontBiz
  • Larner First-Years Present MedQuest Program to Bennington County High Schoolers
    (AUGUST 9, 2022) Five high school students from Bennington County recently completed a MedQuest 2.0 program designed and delivered by first-year medical students from the Robert Larner College of Medicine to gain a richer understanding of health careers available to them in Vermont.
    Read full story at Bennington Banner
  • Center on Rural Addiction Studies Access to Medication-Assisted Treatment for Opioid Use in Maine
    (AUGUST 5, 2022) A new survey by UVM’s Center on Rural Addiction — which is headed by Stacey Sigmon, Ph.D., professor of psychiatry — working with the University of Southern Maine’s Cutler Institute highlights challenges in access to medication-assisted treatment for opioid use disorders in Maine’s rural areas.
    Read full story at Sun Journal (Lewiston, Maine)
  • Lahey Interviewed by Vermont Public about Monkeypox
    (AUGUST 1, 2022) After the World Health Organization declared monkeypox a global health emergency and the first case of the virus was recently confirmed in Vermont, Tim Lahey, M.D., M.M.Sc., professor of medicine, spoke with Vermont Public about what we need to know about the virus, and who’s at highest risk.
  • Lounsbury Quoted in Social Work Today Article
    (AUGUST 1, 2022) Karen Lounsbury, Ph.D., professor of pharmacology and director of foundations and preclinical assessment, is quoted in an article in “Social Work Today” on integrating service delivery by medical or physical health providers, behavioral health providers, and social service providers.
  • Telegraph Quotes King on ‘Vermonters Taking Action Against Cancer’ Program
    (JULY 31, 2022) In response to statistics showing that lung cancer kills more Vermonters than breast, prostate, and colorectal cancers combined, family medicine professor John King, M.D., and colleagues at the UVM and Dartmouth Cancer Centers are spearheading a new community education program called Vermonters Taking Action Against Cancer, the (Nashua, N.H.) Telegraph reported.
    Read full story at The (Nashua, N.H.) Telegraph
  • The Cancer Letter Features Yates Reflecting on Starting UVM Cancer Center
    (JULY 29, 2022) Retired oncology professor Jerome Yates, M.D., spoke with Alexandria Carolan, a reporter with The Cancer Letter and associate editor of the Cancer History Project, about building a cancer center at the University of Vermont.
    Read full story at The Cancer Letter
  • Diehl Comments to CT Insider on Yale’s Omicron-specific mRNA Vaccine
    (JULY 28, 2022) Sean Diehl, Ph.D., associate professor of microbiology and molecular genetics, spoke with CT Insider about an Omicron-specific mRNA vaccine developed by Yale scientists that creates a strong antibody response against subvariants BA.1 and BA.2.12.1.
    Read full story at CT Insider
  • Gosselin Talks Monkeypox in CreakyJoints
    (JULY 28, 2022) Rheumatologist Jeanne Gosselin, M.D., assistant professor of medicine, spoke with CreakyJoints about what monkeypox is and what people who are immunocompromised because of an autoimmune or inflammatory health condition or taking immunosuppressant medication need to know.
    Read full story at CreakyJoints.org